Background: Respiratory exacerbations (RE) are an important outcome measure for research and clinical evaluation in Cystic Fibrosis (CF). Fuchs et al. proposed a standard definition of RE for CF, but there is little data regarding the rate of RE in CF. What evidence exists is inconsistent and fails to differentiate between hospitalized or non-hospitalized patients. Objectives: To determine the RE rate (RER) in Pediatric CF patients and in specific CF pathologies. Methods: A retrospective review of hospital admissions over a 1 year period (2010) were evaluated using Fuchs' RE criteria. These admissions were then examined for factors which might affect RER. Results: Of 124 patients, 76 admissions were observed. 17 for non respiratory problems and 18 for 1 st growth Pseudomonas. 41 admissions met RE criteria (RER per patient: 41/124 = 0.33). 5 (4%) patients had 14 admissions due to ABPA (RER = 2.8), 8 (6%) patients growing atypical mycobacteria, 2 admissions were observed (RER = 0.25), in 5 (4%) patients colonised with Burkholderia cepacia 2 admissions were recorded (RER = 0.4). 12 admissions were seen in 4 (3%) patients with severe disease (FEV1 <55%) (RER = 3.0), and 5 admissions in 7 (5%) patients who were non-compliant (RER = 0.7). In 45 patients aged 6−18 yrs considered stable 5 admissions were observed (RER = 0.11). Conclusions: RE rates vary depending on underlying infection and clinical status. ABPA, atypical mycobacteria, B. cepacia and severe lung disease may increase risk of RE. When reporting RE, it is important to define criteria for RE, but also the CF population to which this measure is applied. The prevalence of MRSA infection is increasing in both the general population and CF patients. We hypothesized that MRSA infection is associated with more severe disease than MSSA infection in CF. Objective: To compare clinical and functional features of CF patients chronically colonized with MRSA and MSSA. Material and Methods: Observational, cross-sectional study. Clinical reports from patients attended at our Center during 2011 were reviewed. Age, gender, genetics, BMI Z-score, FEV 1 , intravenous antibiotics were analyzed in chronically SA infection, positive to MRSA or MSSA (more than 50% of at least 4 sputum cultures during the year). Patients who were also colonized with Pseudomonas aeruginosa or Burkholderia cepacia were excluded. Results: From 110 patients, 33 (30%) were chronically infected with SA (39% MRSA and 61% MSSA). From these, 10 patients in the MRSA group and 5 in the MSSA group were colonized with other bacteria, so they were excluded. In the MRSA group (7 females: 54%) the median current age was 8 years old (6 to 12 interquartile range) and in MSSA group (8 female: 40%) was 5 years old (3 to 10 interquartile range). In the MRSA group 46% had p.F508del mutation homozygous while 55% in MSSA group. The median BMI Zscore was −0.15 (−0.7 to 0.1) in the MRSA group and −0.06 (−0.4 to 0.3) in the MSSA group. (p = NS). The median FEV 1 was 75% (70 to 88) of predictive values in MRSA group and 99% (85 to 105) in MSSA group (p = 0.03). There were 1 (1 to 2) iv antibiotic courses in MRSA group and 0 (0 to 1) in MSSA group (p = 0.01). Conclusion: CF patients chronically colonized with MRSA had a diminished pulmonary function and required more intravenous antibiotic courses.
